Evidence map›Paper›PMID 42515640›Full record

ArticleViruses2026

Joint Monitoring and Early Warning of SARS-CoV-2 in Outdoor PM

Wenli Wang, Haizhou Liu, Dan Wang, Zhiwei Chen, Yu Jiang, Jianjun Xiang, Jing Li, Xiaoyang Zhang, Chuancheng Wu

Abstract read
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wenli WangSchool of Public Health, Fujian Medical University, Fuzhou 350122, China.
Haizhou LiuDepartment of Infectious Diseases, Fuzong Clinical Medical College, Fujian Medical University, Fuzhou 350122, China.
Dan WangSchool of Public Health, Fujian Medical University, Fuzhou 350122, China.
Zhiwei ChenThe Affiliated Fuzhou Center for Disease Control and Prevention, Fujian Medical University, Fuzhou 350200, China.
Yu JiangSchool of Public Health, Fujian Medical University, Fuzhou 350122, China.ORCID 0000-0003-4045-1634
Jianjun XiangSchool of Public Health, Fujian Medical University, Fuzhou 350122, China.ORCID 0000-0001-8107-2580
Jing LiSchool of Public Health, Fujian Medical University, Fuzhou 350122, China.
Xiaoyang ZhangThe Affiliated Fuzhou Center for Disease Control and Prevention, Fujian Medical University, Fuzhou 350200, China.
Chuancheng WuSchool of Public Health, Fujian Medical University, Fuzhou 350122, China.ORCID 0000-0003-2101-4738

Funding

Fujian Medical University XRCZX2021008Fujian Medical University Y21014
6 · The paper itself

Abstract

backgroundFine particulate matter (PM

methodsPM

resultsSARS-CoV-2 was detected in 45.9% of PM

conclusionsSARS-CoV-2 signals in PM

Indexed as

COVID-19Environmental MonitoringParticulate MatterSARS-CoV-2WastewaterAir PollutantsChinaHumansRNA, ViralAir PollutantsParticulate MatterRNA, ViralWastewaterCOVID-19early warningjoint monitoringlag effectPM2.5SARS-CoV-2wastewater

Identifiers

PMID42515640
PMCPMC13431594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.